US EPA

7085696 

Journal Article 

A tracer kinetic model for F-18-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET 

Green, LA; Nguyen, K; Berenji, B; Iyer, M; Bauer, E; Barrio, , JR; Namavari, M; Satyamurthy, N; Gambhir, SS; , 

2004 

SOC NUCLEAR MEDICINE INC 

RESTON 

1560-1570 

15347725 

WOS:000223809500025 

Reporter probe 9-(4-F-18-fluoro-3-[hydroxymethyl]butyl)guanine (F-18-FHBG) and reporter gene mutant herpes simplex virus type 1 thymidine kinase (HSV1-sr39tk) have been used for imaging reporter gene expression with PET. Current methods for quantitating the images using the percentage injected dose per gram of tissue do not distinguish between the effects of probe transport and subsequent phosphorylation. We therefore investigated tracer kinetic models for F-18-FHBG dynamic microPET data and noninvasive methods for determining blood time-activity curves in an adenoviral gene delivery model in mice. Methods: F-18-FHBG (similar to7.4 MBq [similar to200 muCi]) was injected into 4 mice; F-18-FHBG concentrations in plasma and whole blood were measured from mouse heart left ventricle (LV) direct sampling. Replication-incompetent adenovirus (0-2 X 10(9) plaqueforming units) with the E1 region deleted (n = 8) or replaced by HSV1-sr39tk (n = 18) was tail-vein injected into mice, Mice were dynamically scanned using microPET (similar to7.4 MBq [similar to200 muCi] F-18-FHBG) over 1 h; regions of interest were drawn on images of the heart and liver. Serial whole blood F-18-FHBG concentrations were measured in 6 of the mice by LV sampling, and 1 leastsquares ratio of the heart image to the LV time-activity curve rl was calculated for all 6 mice. For 2 control mice and 9 mice expressing HSV1-sr39tk, heart image (input function) and iver image time-activity curves (tissue curves) were fit to 2- and 3-compartment models using Leven berg-M arquardt nonlinear regression. The models were compared using an F statistic. HSV1 -sr39TK enzyme activity was determined from liver samples and compared with model parameter estimates. For another 3 control mice and 6 HSV1-sr39TK-positive mice, the model-predicted relative percentage of metabolites was compared with h igh- performance liquid chromatography analysis. Results: The ratio of F-18-FHBG in plasma to whole blood was 0.84 +/- 0.05 (mean +/- SE) by 30 s after injection. The least- squares ratio of the heart image time-activity curve to the LV time-activity curve was 0.83 +/- 0.02, consistent with the recovery coefficient for the partial-volume effect (0.81) based on independent measures of heart geometry. A 3-compartment model best described F-18-FHBG kinetics in mice expressing HSV1-sr39tk in the liver; a 2-compartment model best described the kinetics in control mice. The 3-compartment model parameter, k(3), correlated well with the HSV1-sr39TK enzyme activity (r(2) = 0.88). Conclusion: F-18-FHBG equilibrates rapidly between plasma and whole blood in mice. Heart image timeactivity curves corrected for partial-volume effects well approximate LV time-activity curves and can be used as input functions for 2- and 3-compartment models. The model parameter k(3) from the 3-compartment model can be used as a noninvasive estimate for HSV1-sr39TK reporter protein activity and can predict the relative percentage of metabolites. 

47th Annual Meeting of the Society-of-Nuclear-Medicine 

St Louis, MO